Tradestie Institutional Equity Comparison Engine

SLDB vs ARVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLDB Overall Edge

SLDB Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Solid Biosciences Inc. Common Stock (SLDB) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ARVN counters with relative strength in Valuation. Fundamentally, SLDB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus ARVN at 17.9x Forward P/E and -10.1% operating margin (-98.8% YoY). In options structure, SLDB sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro) against ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARVN
SLDB N/M vs ARVN 17.9x Fwd P/E
Growth & Margin Winner SLDB
Op Margin 0.0% vs -10.1% ยท YoY -100.0% vs -98.8%
Momentum & Technical Winner SLDB
1Y +52.7% vs -33.4% ยท 52W Pos 33% vs 5%
Options & Structure Winner SLDB
BREAKDOWN (15th %ile IV) vs BREAKDOWN (25th %ile IV)
SLDB NASDAQ
Solid Biosciences Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$6.57
-4.02% 1D
Market Cap $781.3M
1M Return +18.72%
1Y Return +52.67%
Forward P/E N/M
Unified AI Score
36.5 / 100 SELL
Tech 15.0 Fund 36.0 Flow 70.0 Mom 40.0
ARVN NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap $449.9M
1M Return -3.3%
1Y Return -33.4%
Forward P/E 17.9x
Unified AI Score
52.9 / 100 HOLD
Tech 54.0 Fund 59.0 Flow 71.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SLDB +52.67% ARVN -33.4% Spread: +86.07 pp (SLDB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SLDB Revenue ARVN Revenue SLDB Op. Margin ARVN Op. Margin Margin Edge
FY2018 N/A $10M N/A -306.3% ARVN
FY2019 N/A $20M N/A -281.4% ARVN
FY2020 N/A $20M N/A -554.1% ARVN
FY2021 $10M $50M -530.5% -403.4% ARVN
FY2022 $10M $130M -1315.2% -200.3% ARVN
FY2023 N/A $80M N/A -511.5% ARVN
FY2024 N/A $260M N/A -95.0% ARVN
FY2025 N/A $260M N/A -45.1% ARVN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SLDB (4) vs ARVN (6)
Institutional Metric SLDB ARVN Criterion Row Winner
Market Capitalization Scale $781.3M $449.9M Larger Scale SLDB
Trailing P/E Ratio Valuation N/M 17.9x Lower Multiple ARVN
Forward P/E Ratio Valuation N/M 17.9x Lower Multiple ARVN
Revenue Growth (YoY) Growth -100.0% -98.8% Higher Growth ARVN
Operating Margin (TTM) Profitability 0.0% -10.1% Higher Margin SLDB
Net Profit Margin Profitability 0.0% -3.5% Higher Margin SLDB
Return on Equity (ROE) Capital Efficiency -76.9% -1.8% Higher ROE ARVN
52-Week Range Position Momentum 33% ($4โ€“$11) 5% ($6โ€“$15) Stronger Trend SLDB
Beta / 30D Volatility Risk Regime 2.14ฮฒ ยท 76% Vol 1.40ฮฒ ยท 66% Vol Lower Realized Risk ARVN
Unified Institutional Score Composite Signal 36.5 / 100 (SELL) 52.9 / 100 (HOLD) Higher Composite ARVN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SLDB vs ARVN Buy Guide
SLDB BREAKDOWN
93d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live SLDB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARVN BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ARVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SLDB nor ARVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.